Mengis Capital Management’s GE HealthCare GEHC Stock Holding History

Mengis Capital Management’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.27M	Sell	45,907 -3,290	-7%	-$259K	0.56%	50
2025 Q4	$4.04M	Sell	49,197 -1,360	-3%	-$106K	0.71%	38
2025 Q3	$3.8M	Sell	50,557 -390	-0.8%	-$29.1K	0.75%	38
2025 Q2	$3.77M	Buy	50,947 +2,845	+6%	+$198K	0.8%	35
2025 Q1	$3.88M	Buy	48,102 +3,740	+8%	+$321K	0.81%	36
2024 Q4	$3.47M	Buy	44,362 +10,685	+32%	+$908K	0.71%	36
2024 Q3	$3.16M	Buy	33,677 +11,685	+53%	+$981K	0.62%	46
2024 Q2	$1.71M	Buy	21,992 +4,818	+28%	+$393K	0.35%	76
2024 Q1	$1.56M	Buy	17,174 +867	+5%	+$72.1K	0.24%	86
2023 Q4	$1.26M	Buy	16,307 +11,875	+268%	+$832K	0.24%	84
2023 Q3	$302K	Buy	4,432 +190	+4%	+$13.8K	0.06%	140
2023 Q2	$345K	Buy	+4,242	New	+$339K	0.07%	135

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Mengis Capital Management's GEHC Position: Q1 2026 in Review

Mengis Capital Management reduced its GE HealthCare (GEHC) stake by 6.7% in Q1 2026, selling an estimated $259K and leaving 45,907 shares worth $3.27M. The position accounts for 0.56% of the portfolio, ranked #50.

Mengis Capital Management first reported a position in GEHC in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.04M in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Mengis Capital Management held 45,907 shares of GE HealthCare worth $3.27M as of Q1 2026.
Mengis Capital Management sold 3,290 GE HealthCare shares in Q1 2026, an estimated $259K.
GE HealthCare made up 0.56% of Mengis Capital Management's portfolio in Q1 2026, its #50 holding.
Mengis Capital Management first reported a position in GE HealthCare in Q2 2023 and has held it in 12 quarters since.
Mengis Capital Management's GE HealthCare position peaked at $4.04M in Q4 2025.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.